Literature DB >> 16807905

Vanishing white matter disease: a review with focus on its genetics.

Jan C Pronk1, Barbara van Kollenburg, Gert C Scheper, Marjo S van der Knaap.   

Abstract

Leukoencephalopathy with vanishing white matter (VWM) is an autosomal recessive brain disorder, most often with a childhood onset. Magnetic resonance imaging and spectroscopy indicate that, with time, increasing amounts of cerebral white matter vanish and are replaced by fluid. Autopsy confirms white matter rarefaction and cystic degeneration. The process of localization and identification of the first two genes related to VWM, EIF2B5 and EIF2B2, was facilitated by two founder effects in the Dutch population. EIF2B5 and EIF2B2 encode the epsilon and beta subunits of translation initiation factor eIF2B. Soon it was shown that mutations in all five eIF2B subunit genes can cause VWM. EIF2B is essential for the initiation of translation of RNA into protein and is involved in regulation of the process, especially under stress conditions, which may explain the sensitivity to stress conditions observed in VWM patients. The pathophysiology of the disease is still poorly understood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807905     DOI: 10.1002/mrdd.20104

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  30 in total

1.  Clinical and neuroimaging findings of Cree leukodystrophy: a retrospective case series.

Authors:  S Harder; A Gourgaris; E Frangou; K Hopp; R Huntsman; N Lowry; S Seshia; E Lemire; C Robinson; J Tynan
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

2.  Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.

Authors:  Irit Gat-Viks; Tamar Geiger; Mali Barbi; Gali Raini; Orna Elroy-Stein
Journal:  J Neurochem       Date:  2015-05-14       Impact factor: 5.372

3.  The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus.

Authors:  Rachel Elsby; Joshua F Heiber; Peter Reid; Scot R Kimball; Graham D Pavitt; Glen N Barber
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Identification of variants in pleiotropic genes causing "isolated" premature ovarian insufficiency: implications for medical practice.

Authors:  Elena J Tucker; Sonia R Grover; Gorjana Robevska; Jocelyn van den Bergen; Chloe Hanna; Andrew H Sinclair
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 5.  eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Authors:  Christopher J Carter
Journal:  Schizophr Bull       Date:  2007-02-27       Impact factor: 9.306

6.  Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis.

Authors:  Lulu Xu; Meixiang Zhong; Yuyuan Yang; Meng Wang; Nina An; Xin Xu; Yufeng Zhu; Zengwen Li; Huili Chen; Renliang Zhao; Xueping Zheng
Journal:  Neurol Sci       Date:  2021-11-09       Impact factor: 3.307

7.  Role of Saccharomyces cerevisiae TAN1 (tRNA acetyltransferase) in eukaryotic initiation factor 2B (eIF2B)-mediated translation control and stress response.

Authors:  Sonum Sharma; Anuradha Sourirajan; Kamal Dev
Journal:  3 Biotech       Date:  2017-07-04       Impact factor: 2.406

8.  Vanishing white matter disease with different faces.

Authors:  Gülay Güngör; Olcay Güngör; Seda Çakmaklı; Hülya Maraş Genç; Hülya İnce; Gözde Yeşil; Cengiz Dilber; Kürşad Aydın
Journal:  Childs Nerv Syst       Date:  2019-08-05       Impact factor: 1.475

9.  Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.

Authors:  Yuval Cabilly; Mali Barbi; Michal Geva; Liraz Marom; David Chetrit; Marcelo Ehrlich; Orna Elroy-Stein
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

10.  A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.

Authors:  Rogerio A de Almeida; Anne Fogli; Marina Gaillard; Gert C Scheper; Odile Boesflug-Tanguy; Graham D Pavitt
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.